Selecting patients for home treatment of deep vein thrombosis: The problem of cancer

Haematologica

Volumn 87, Issue 3, 2002, Pages 286-291

  Ageno, Walter ^a   Steidl, Luigi ^a   Marchesi, Chiara ^a   Dentali, Francesco ^a   Mera, Valentina ^a   Squizzato, Alessandro ^a   Crowther, Mark A ^a   Venco, Achille ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Cancer; Deep vein thrombosis; Outpatient treatment

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; ORAL CONTRACEPTIVE AGENT; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; CANCER; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HOME CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PATIENT SELECTION;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; COHORT STUDIES; COMORBIDITY; FEMALE; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 0036197487     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
2. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
3. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin
4. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: A comparison of patient self-injection with homecare injection
5. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low molecular weight heparin: The Vascular Midi-Pyrenees study
6. Eligibility for outpatient treatment with low-molecular-weight heparin in venous thromboembolism
7. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer
8. Venous thromboembolism and occult malignancy
9. Treatment of venous thromboembolism in cancer patients
10. Antithrombotic strategies in patients with cancer
11. Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: Clinical implications of the site of vein noncompressibility
12. Idiopathic deep venous thrombosis: The value of routine and pelvic computed tomographic scanning
13. Occult cancer in patients with deep venous thrombosis. A systematic approach
14. Occult cancer in patients with venous thromboembolism: Which patients, which cancers
15. The incidence of occult cancer in patients with deep venous thrombosis: A prospective study
16. Extensive screening for occult malignant disease in idiopathic venous thromboembolism. A prospective randomized clinical trial